About Us / Business Model
HRA Pharma has a proven track record of developing, registering and commercializing products in its key therapeutic areas of reproductive health and endocrine diseases.
The company has chosen to concentrate its resources on strategic components of the value chain, including drug development, regulatory affairs, international marketing and business development. For other key activities, the company relies on relationships with specialized partner companies and organizations.
HRA Pharma distributes and markets its products either directly (in the European Union) or via license agreements. In addition to high-quality products, HRA Pharma prides itself on providing users and healthcare providers with comprehensive information and associated services.